|
Alydar Pharmaceuticals' partnering and business development goals are to
establish strategic collaborative R&D relationships with selected genomics,
proteomics, and other biotech and pharmaceutical companies having novel drug
targets, screening methods, and disease models. We also seek opportunities
to license infochemical-derived drug candidates to companies with
commercialization expertise and market presence in the relevant disease
areas.
Alydar is forming collaborative relationships with contract research
companies and academic institutions, and is seeking in-licensing
opportunities in its areas of strategic focus.
For more information contact:
Dr. Rivka Sherman-Gold
President & CEO
650-316-3666
Rivka@alydarpharma.com
|
 |
